Trials / Sponsors / Avenge Bio, Inc
Avenge Bio, Inc
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary Neoplasm, Ovarian, Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer | Phase 1 / Phase 2 | 2022-12-09 |